Table 1.
Demographic and clinical characteristics of invasive cervical cancer patients stratified by HIV status (n = 126)
| Characteristic | HIV-uninfected n = 38 | HIV-infected n = 88 | p-value1 |
|---|---|---|---|
| Age in years | |||
| <50 | 4 (10.5%) | 57 (64.8%) | <0.0001 |
| ≥50 | 34 (89.5%) | 31 (35.2%) | |
| Age in years, median (IQR) | 61 (55–68) | 45 (39–52) | <0.00012 |
| Cancer stage | |||
| Stage I, II | 19 (50.0%) | 58 (65.9%) | 0.093 |
| Stage III, IV | 19 (50.0%) | 30 (34.1%) | |
| Nadir CD4 (cells/μl) | |||
| ≥350 | N/A | 23 (26.1%) | N/A |
| <350 | N/A | 62 (70.5%) | |
| Missing data | N/A | 3 (3.4%) | |
| Baseline CD4 (cells/μl) | |||
| ≥350 | N/A | 57 (64.8%) | N/A |
| <350 | N/A | 24 (27.3%) | |
| Missing data | N/A | 7 (7.9%) | |
| Baseline CD4 (cells/μl), median (IQR) | N/A | 487 (325–600) | N/A |
| Months on ART | |||
| ≤60 months | N/A | 42 (47.7%) | N/A |
| >60 months | N/A | 40 (45.5%) | |
| Missing data | N/A | 6 (6.8%) |
1
Based on Chi-squared test when data counts were sufficient for statistical analysis.
2
Based on Mann–Whitney test.
Abbreviations: IQR, interquartile range; ART, antiretroviral therapy; N/A, not applicable.